InvestorsHub Logo
Followers 24
Posts 686
Boards Moderated 0
Alias Born 09/27/2010

Re: blue_skies post# 2165

Monday, 06/11/2018 8:17:46 AM

Monday, June 11, 2018 8:17:46 AM

Post# of 2463
My thoughts exactly.

Another company can look at REPR and view the very good margins and see a way to take out half(?) of the SG&A spend. I'd argue that some will model up to 70% but I've never seen one actually be able to meet 50%.

Add in the fact that the product is useful to both a medical device company and to the drug mfgr's themselves potentially.